Citywire for Financial Professionals

Syncona (Ordinary Share) SYNC

Sector Specialist: Biotechnology/Life Sciences

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Add to Virtual Portfolio | Print page

Estimated NAV

151.00

Share Price

N/A

Total Returns on £1000 over 

Fund / Benchmark Total returns(%)
Syncona (Ordinary Share) Price 38.32%
Syncona (Ordinary Share) NAV 14.80%
Total Returns on £1000

Discount / Premium Movement

Discount / Premium Movement

Shares

Share Type Yesterday's
Closing Price
Discount / Premium Diluted NAV Gearing Dividend
Est Last
Ordinary Share 198.0 31.3% 151.00 150.00
31 Jan
100%

Discrete performance % over

Fund / BenchmarkQ1Q2Q3Q4
Syncona (Ordinary Share) Price19.468.799.95-3.20
Syncona (Ordinary Share) NAV5.8115.95-6.31-0.12

Discrete performance over

Discrete Performance

Top 10 Holdings

Polygon European Equity Opportunity Fund 4.95%
Polar Capital Japan Alpha Fund 4.62%
The SFP Value Realization Fund 4.19%
Polar UK Absolute Equity Fund 3.98%
Majedie Asset UK Equity 3.87%
Parity Value Fund 3.87%
Maga Smaller Companies Fund 3.44%
AKO Global UCITS Fund 3.33%
Sinfonietta Fund 3.01%
Portland Hill 2.90%

Sectors weighting

Life Science 51.00%
Equity Hedge 26.00%
General Equity 24.00%
Equity Non- Hedge 17.00%
Other Hedge Strategies 17.00%
Cash/Cash Equivalent 7.00%
Net Current Assets 7.00%
Credit 6.00%
Macro 6.00%
Unlisted Equities 3.00%
Fixed Interest 2.00%
Infrastructure 1.00%
  • Investment trust info:

  • Sector Sector Specialist: Biotechnology/Life Sciences
  • Launch Date 26 Oct 2012
  • Currency GBX
  • Domicile Guernsey
  • Share Price N/A
  • Share Type Ordinary Share
  • TIDM SYNC
  • ISIN GG00B8P59C08
  • Shares Issued (M) 660
  • Market Capital (£M) 1306.71
  • Gross Assets (£M) 995.60
  • Net Assets (£M) 995.60
  • TER (%) 1.45
  • Last AGM 08 Sep 2017
  • Next AGM 10 Sep 2018
  • Last Annual Report Date 01 Aug 2016
  • Next due Report Date 31 Mar 2017
  • Next due Report Type A/R
  • Objective:

  • To deliver superior returns from investments in life science businesses, leading long-only and alternative investment funds across multiple asset classes.
  • Management Group(s):

  • BACIT Investments LP
  • Syncona Investment Management Limited
  • Managed by:

  • John McDonald Start: 26 Oct 2012
  • Thomas Henderson Start: 26 Oct 2012
  • Management Contract & Fees:

    BACIT (UK) Limited is the Company's Investment Manager. The operating expenses of the Investment Manager are covered by a Management Expense Contribution, payable by the Company to the Investment Manager, equal to 0.15% of p.a. of NAV.

Sorry, this link is not
quite ready yet